{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(2)"],"submitter":["Weiss L"],"funding":["Paracelsus Medical University"],"pubmed_abstract":["This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and CodeBreaK101 trials, (2) positive phase 3 data on the possible role of selective internal radiotherapy (SIRT) in the second-line treatment of liver-limited metastatic CRC, and (3) the impact of the coronavirus disease 2019 (COVID-19) pandemic on CRC screening, management and mortality, now and in the upcoming years<i>.</i>"],"journal":["Memo"],"pagination":["114-116"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9047589"],"repository":["biostudies-literature"],"pubmed_title":["ESMO 2021-highlights in colorectal cancer."],"pmcid":["PMC9047589"],"pubmed_authors":["Weiss L"],"additional_accession":[]},"is_claimable":false,"name":"ESMO 2021-highlights in colorectal cancer.","description":"This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and CodeBreaK101 trials, (2) positive phase 3 data on the possible role of selective internal radiotherapy (SIRT) in the second-line treatment of liver-limited metastatic CRC, and (3) the impact of the coronavirus disease 2019 (COVID-19) pandemic on CRC screening, management and mortality, now and in the upcoming years<i>.</i>","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-18T12:13:29.32Z","creation":"2025-04-06T21:52:15.246Z"},"accession":"S-EPMC9047589","cross_references":{"pubmed":["35505999"],"doi":["10.1007/s12254-022-00808-7"]}}